Edap Tms (NASDAQ:EDAP) Lowered to Sell Rating by StockNews.com

StockNews.com downgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a research note released on Tuesday morning.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $19.00 target price on shares of Edap Tms in a report on Thursday, August 29th.

Edap Tms Stock Down 4.0 %

EDAP stock opened at $2.37 on Tuesday. The firm has a market cap of $87.94 million, a price-to-earnings ratio of -3.65 and a beta of 0.38. Edap Tms has a 1-year low of $2.27 and a 1-year high of $8.50. The firm has a fifty day moving average price of $2.71 and a two-hundred day moving average price of $4.11. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The business had revenue of $16.97 million during the quarter, compared to analyst estimates of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Research analysts predict that Edap Tms will post -0.6 EPS for the current year.

Institutional Investors Weigh In On Edap Tms

Hedge funds have recently added to or reduced their stakes in the stock. Orion Capital Management LLC increased its stake in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after purchasing an additional 6,600 shares during the period. Parkman Healthcare Partners LLC acquired a new position in shares of Edap Tms during the third quarter worth approximately $395,000. BNP Paribas Financial Markets grew its holdings in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 4,400 shares in the last quarter. Redhawk Wealth Advisors Inc. acquired a new stake in Edap Tms in the 3rd quarter valued at approximately $36,000. Finally, Commonwealth Equity Services LLC raised its stake in Edap Tms by 5.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after acquiring an additional 4,000 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.